The Retina Group of New York is offering SYFOVRE™, a revolutionary treatment option for age-related dry macular degeneration (AMD) with geographic atrophy. We are thrilled to offer SYFOVRE to our ...
Most people recognize subtle changes to their eyesight around midlife. By age 75, half will develop cataracts, a condition ...
Retina Group of New York introduces IZERVAY™, a Safe and Effective Treatment for Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA). We are thrilled to offer IZERVAY, a new drug ...
BIRMINGHAM - For the 76 million baby boomers born in the U.S. between 1946 and 1964, the fear of facing permanent vision loss due to Age-Related Macular Degeneration (AMD) is very real. AMD is the ...
Most older adults - around 70 percent - have experienced squiggly lines and wispy eye “floaters” that obscure or impact their vision. This increasingly happens as people age, due to changes inside the ...